Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:37:35 EDT Sat 20 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:AWKNF from 2023-04-20 to 2024-04-19 - 21 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-17 07:31U:AWKNFNews ReleaseAwakn Life Sciences Announces Closing of Tranche of Private Placement
2024-04-03 07:31U:AWKNFNews ReleaseAwakn Life Sciences Announces Launch of Licensing Partnership Agreement with Oklahoma Based Clinic
2024-02-12 07:33U:AWKNFNews ReleaseAwakn Life Sciences Announces Listing on the Canadian Securities Exchange
2024-02-05 07:31U:AWKNFNews ReleaseAwakn Life Sciences Announces Conditional Approval of CSE Listing
2024-01-24 07:31U:AWKNFNews ReleaseAwakn Life Sciences Completes Successful Investigative Study to Establish Dissociative Effect of a Proprietary Sublingual S-Ketamine Oral Thin Film Formulation in Harmful Drinkers
2023-12-20 07:31U:AWKNFNews ReleaseAwakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S-Ketamine Formulation With LTS
2023-12-15 07:31U:AWKNFNews ReleaseAwakn Life Sciences Provides Corporate Update
2023-11-15 07:31U:AWKNFNews ReleaseAwakn Life Sciences Receives Regulatory and Ethical Approval for Phase III Clinical Trial of AWKN-P001
2023-11-10 17:01U:AWKNFNews ReleaseAwakn Life Sciences Announces Receipt of Notice of Non-Compliance with Cboe Exchange Continued Listing Requirements
2023-10-31 07:31U:AWKNFNews ReleaseAwakn Life Sciences Engages Orphan Insight Ltd. to Advance Market Access, Pricing, and Reimbursement Strategies for AWKN-P001 Targeting Severe Alcohol Use Disorder
2023-10-04 08:31U:AWKNFNews ReleaseAwakn Life Sciences Completes MDMA Zydis(R) ODT Feasibility Study
2023-09-14 07:31U:AWKNFNews ReleaseAwakn Life Sciences Provides Corporate Update
2023-09-06 07:31U:AWKNFNews ReleaseAwakn Life Sciences Submits Clinical Trial Application for Phase III Trial of AWKN-P001
2023-08-01 07:31U:AWKNFNews ReleaseAwakn Life Sciences Completes Sale of Awakn Clinics In Norway
2023-07-05 07:31U:AWKNFNews ReleaseAwakn Life Sciences Completes Sale of Awakn Clinics London
2023-06-27 17:01U:AWKNFNews ReleaseAwakn Life Sciences Announces Results of Annual General and Special Meeting
2023-06-19 07:31U:AWKNFNews ReleaseAwakn Life Sciences to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC
2023-06-15 07:31U:AWKNFNews ReleaseAwakn Life Sciences Announces Closing of the Second Tranche and Upsizing of Previously Announced Private Placement
2023-06-09 12:01U:AWKNFNews ReleaseAwakn Life Sciences to Focus Solely on Research and Development of Therapeutics Targeting Addiction
2023-04-28 07:31U:AWKNFNews ReleaseAwakn Life Sciences Reports Q4 2023 and Annual Results
2023-04-26 08:19U:AWKNFNews ReleaseAwakn Life Sciences Announces Private Placement